Working… Menu

A Phase II Trial of LDK378 in ROS1 and /or ALK Over-expressed Advanced Intrahepatic or Hilar Cholangiocarcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02374489
Recruitment Status : Terminated (ROS1 in IHC and gene rearrangement result can not match。No tumor response。)
First Posted : February 27, 2015
Last Update Posted : April 5, 2018
National Cheng-Kung University Hospital
National Taiwan University Hospital
Information provided by (Responsible Party):
National Health Research Institutes, Taiwan

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : January 2018
Actual Study Completion Date : January 2018